简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2020-12-02 09:52 LianBio Announces Clearance to Initiate in China the Phase 2a Trial of Infigratinib in Patients with Locally Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma with FGFR2 Gene Amplification
2020-12-01 15:05 Study Comparing Two Noninvasive Indicators of Fluid Responsiveness on Mechanically Ventilated Patients Finds Masimo PVi® Effective and Advantageous
2020-12-01 11:03 New Studies Conclude Xlear Kills and/or Deactivates SARS-CoV-2
2020-12-01 09:54 Takeda Completes Sale of Select OTC and Non-Core Assets to Celltrion in Asia Pacific
2020-11-27 15:56 Saudi Urban20 Chair Wishes Italy ‘Buona Fortuna’ With the 2021 Urban20 Presidency
2020-11-27 13:22 Fitbit and JMDC Sign Agreement to Appoint JMDC as Exclusive Distributor of Fitbit Premium for Enterprise Customers in Japan
2020-11-26 14:15 Vifor Pharma supports Iron Deficiency Day 2020 to highlight global impact on health and gender inequality
2020-11-26 09:16 MEDIROM Healthcare Technologies Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering on NASDAQ
2020-11-25 15:16 Mary Kay to Support Sea Turtle Conservation Efforts and Promote Sustainable Eco-tourism Practices With the Nature Conservancy in the Solomon Islands
2020-11-25 14:40 Announcing Intellicentrics Newly Created “5th Ring Advisory Board”
2020-11-25 12:04 Patient Safety Movement Foundation Launches New Commitment Model Supporting Mission to Achieve Zero Preventable Patient Deaths By 2030
2020-11-24 18:25 Humanigen Australia Proprietary Limited Established to Facilitate Asia-Pacific Growth Plans
2020-11-23 13:42 Walgreens Reinvents Nation’s Largest Health and Wellbeing-centered Loyalty Program with myWalgreens to Offer Customers Many More Benefits
2020-11-20 10:26 Pfizer and LianBio Announce Strategic Collaboration to Expand Development of Novel Therapeutics in Greater China
2020-11-19 14:54 VFMCRP and Fresenius Kabi expand collaboration in nephrology in China with Veltassa® agreement
2020-11-19 09:47 Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME® trial
2020-11-18 18:40 PierianDx and Bench International Announce the Appointment of Mark McDonough as New CEO
2020-11-18 14:31 EcoTT's Eco-friendly Masks and Barley Sprout Products Increasing Sales Amid Prolonged COVID-19
2020-11-17 14:57 Study Investigates Effects of Patient Blood Management Program with Masimo SpHb®, Noninvasive, Continuous Hemoglobin Monitoring, on Postoperative Cancer Patients
2020-11-17 10:15 Qilu Pharmaceutical and ABEC Continue Large-Scale Bioreactor Partnership